Public Company News

England's NICE recommends FILSPARI® (sparsentan) as a treatment option for IgA nephropathy

First non-immunosuppressive dual-action therapy recommended by NICE for eligible patients with IgA nephropathy, a leading cause of kidney failure1-3 NICE's recommendation is based on clinically meaningful results from the phase-III PROTECT trial4 ST. GALLEN, Switzerland, May 23, 2025 /PRNewswi...

2025-05-23 16:16 4391

Antengene to Present Latest Clinical Results from Two Studies in CPI-resistant Solid Tumors at ASCO 2025

* ATG-037, an oral small molecule CD73 inhibitor, in combination with MSD's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), achieved an overall response rate (ORR) of 36.4% and disease control rate (DCR) of 100% in checkpoint inhibitor (CPI)-resistant melanoma patients in the ongoing STAMINA-01 t...

2025-05-23 12:31 4663

Everest Medicines Announces NEFECON® Inclusion in China's Clinical Practice Guideline for IgA Nephropathy and IgA Vasculitis in Chinese Adults (For Public Review)

SHANGHAI, May 23, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics,announced that NEFECON® has been included in the "Clin...

2025-05-23 11:39 2857

ThunderSoft Showcases Japan-Focused Smart Vehicle Solutions at Automotive Engineering Exposition 2025 Yokohama

YOKOHAMA, Japan, May 22, 2025 /PRNewswire/ -- May 21–23, 2025,ThunderSoft, a global leader in intelligent automotive software, made its debut at the Automotive Engineering Exposition 2025 Yokohama (Booth No. 2-249), presenting its next-generation smart vehicle solutions tailored for the Japanese m...

2025-05-23 10:50 3757

FDA Clearance of Investigational New Drug Application Received for Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418

Phase 1/2 first-in-human clinical study planned this year SHANGHAI and SAN DIEGO, May 22, 2025 /PRNewswire/ -- Duality Biotherapeutics ("DualityBio", HKEX:09606) partner Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company developing next-generation oncology therapies, to...

2025-05-23 10:44 2280

Manhattan Associates Unveils Agentic AI Innovation at Momentum 2025

SYDNEY, May 23, 2025 /PRNewswire/ -- Kicking off Momentum 2025 ,  Manhattan Associates Inc.  (NASDAQ: MANH) today announced sweeping Agentic AI support within Manhattan Active® solutions

2025-05-23 10:21 2515

CARsgen's Satri-cel Abstract Available on ASCO Website

SHANGHAI, May 22, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that an abstract of the research results of the confirmatory Phase II clinical trial of satricabtagene autoleucel ("satri-...

2025-05-23 08:00 2207

Manulife Shares Responsible AI Principles at Reuters Momentum AI Summit

Jodie Wallis, Global Chief Analytics Officer, Outlines How Manulife is Using AI Responsibly C$ unless otherwise stated                                             TSX/NYSE/PSE: MFC     SEHK: 945 TORONTO, May 23, 2025 /PRNewswire/ -- Manulife's Responsible AI Principles  were shared during theRe...

2025-05-23 08:00 4243

Binggrae to Expand Presence in Southeast Asia Through Participation in 'THAIFEX 2025'

SEOUL, South Korea, May 23, 2025 /PRNewswire/ -- Binggrae, South Korea's leading food company, has announced its participation in 'THAIFEX – Anuga Asia 2025,' as part of its broader strategy to expand into Southeast Asian markets.

2025-05-23 08:00 2934

Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) Presented Preclinical Data on GNTbm-38, an Novel Epigenetic Immune Activator, at the 2025 ASCO Annual Meeting

TAIPEI, May 23, 2025 /PRNewswire/ -- GNTbm (stock code: 7427, Taiwan) announced the preclinical data on GNTbm-38, an novel epigenetic immune activator for cancer immunotherapy. GNTbm-38 was presented as posters at the 2025 American Association of Clinical Oncology (ASCO) Annual Meeting, which ...

2025-05-23 08:00 2474

Webull Reports First Quarter 2025 Financial Results

Total revenues grew 32% year-over-year to $117 million, reflecting strong account and trading volume growth Customer assets increased 45% year-over-year, driven by increased customer net deposits Disciplined execution alongside robust revenue growth driving profitability ST. PETERSBURG, Fla....

2025-05-23 04:15 4869

China Liberal Education Holdings Limited Receives Additional Nasdaq Staff Determination Letter of Delinquency

BEIJING, May 22, 2025 /PRNewswire/ -- China Liberal Education Holdings Limited ("China Liberal" or the "Company") (Nasdaq: CLEU), a China-based company that provides technological consulting services for smart campus solutions and other educational services, today announced that on May 21, 2025, ...

2025-05-23 04:05 2206

Innodisk Showcased Embedded and Automation Innovations at Automate Show 2025

DETROIT, May 22, 2025 /PRNewswire/ -- Innodisk, a global leader in edge AI solutions, showcased its latest embedded and automation technologies at the Automate Show 2025, recently held in Detroit. With a sharp focus on advancing AI innovation for industrial applications, Innodisk bridges AI concep...

2025-05-23 00:00 2801

Kavita Kurup Appointed as Chief People Officer of Cyient

HYDERABAD, India and DALLAS, May 22, 2025 /PRNewswire/ -- Cyient Limited, a global Intelligent Engineering solutions company, announced the appointment of Kavita Kurup as Chief People Officer (CPO). Based at the company's Hyderabad headquarters, Kavita will oversee the entire Human Resources func...

2025-05-22 21:30 2019

NYSE Content Advisory: Pre-Market update + Hinge Health, MNTN go public

NEW YORK, May 22, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Kristen Scholer delivers the pre-market update on May 22nd * Hing...

2025-05-22 21:12 4281

Yunji Selects WWC, P.C. as its Independent Registered Public Accounting Firm

HANGZHOU, China, May 22, 2025 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced that the Company's board of directors and the audit committee of the board approved the dismissal of PricewaterhouseCoopers Zhon...

2025-05-22 20:30 4049

KLA Invests in Operations in Wales with the Opening of a $138 Million R&D and Manufacturing Facility

New complex builds on decades of SPTS Technologies' semiconductor equipment innovation MILPITAS, Calif., May 22, 2025 /PRNewswire/ -- KLA Corporation (NASDAQ: KLAC), a global leader in semiconductor process control and process-enabling technology, today announced the opening of its new $138 mil...

2025-05-22 20:00 3934

International Day for Biological Diversity 2025: Shanghai Electric Highlights Global Efforts in Biodiversity Protection, Promoting Harmony with Nature

The Company's innovative technology and management support a world where nature thrives and harmony endures. SHANGHAI, May 22, 2025 /PRNewswire/ -- Shanghai Electric  (SEHK:2727, SSE:601727) marked International Day for Biological Diversity 2025 on M...

2025-05-22 18:32 4750

SINEXCEL and Phoenix Contact Sign Global Strategic Partnership Agreement

SHENZHEN, China, May 22, 2025 /PRNewswire/ -- SINEXCEL(300693.SZ) has officially signed a global strategic partnership agreement with Phoenix Contact at the PHIIDF (Phoenix Contact Innovation and Industry Development Forum) in Shenzhen. SIN...

2025-05-22 18:12 2560

Waterdrop Inc. to Report First Quarter 2025 Financial Results on June 5, 2025

BEIJING, May 21, 2025 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH ) ("Waterdrop" or the "Company"), a leading technology platform de...

2025-05-22 18:00 4166

Week's Top Stories